No Adverse Impact of Obesity in Biologic-Treated IBD : compa

People with inflammatory bowel disease and obesity can be safely started on biologic therapies, suggests an analysis of over 3000 patients.

Related Keywords

California , United States , Illinois , San Diego , Chicago , La Jolla , American , Clifford Joseph Barborka , Stephenb Hanauer , Siddharth Singh , University Of California , Research Findings , World Health Organization , Northwestern University Feinberg School Of Medicine , American Journal , Medscape Medical , Health Organization , Clifford Joseph Barborka Professor , Northwestern University Feinberg School , Medscape Medical News , Inflammatory Bowel Disease , Nflammatory Bowel Disease Ibd , Bd , Obesity , Bese , Biologic Therapy , Diabetes Mellitus , Ulcerative Colitis , Hospitals , Inpatient Care , Surgery , Anti Tnf , Anti Tumor Necrosis Factor , Body Mass Index Bmi , Cytokines , Monoclonal Antibody , Etuximab , Ituximab , Remission ,